In the past week, CMND stock has gone up by 19.95%, with a monthly decline of -3.46% and a quarterly plunge of -26.32%. The volatility ratio for the week is 10.92%, and the volatility levels for the last 30 days are 7.80% for Clearmind Medicine Inc . The simple moving average for the past 20 days is 9.93% for CMND’s stock, with a -16.75% simple moving average for the past 200 days.
Is It Worth Investing in Clearmind Medicine Inc (NASDAQ: CMND) Right Now?
The stock has a 36-month beta value of -1.31.
The public float for CMND is 2.98M, and at present, short sellers hold a 6.19% of that float. On April 21, 2025, the average trading volume of CMND was 67.43K shares.
CMND) stock’s latest price update
Clearmind Medicine Inc (NASDAQ: CMND)’s stock price has gone rise by 15.46 in comparison to its previous close of 0.97, however, the company has experienced a 19.95% increase in its stock price over the last five trading days. globenewswire.com reported 2025-04-17 that Vancouver, Canada, April 17, 2025 (GLOBE NEWSWIRE) — Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) (“Clearmind” or the “Company”), a clinical-stage biotech company focused on discovery and development of novel psychedelic-derived therapeutics to solve major under-treated health problems, today announced that the United States Patent Office has issued a Notice of Allowance for a patent relating to its MEAI treatment for binge behavior.
CMND Trading at -2.66% from the 50-Day Moving Average
After a stumble in the market that brought CMND to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -51.30% of loss for the given period.
Volatility was left at 7.80%, however, over the last 30 days, the volatility rate increased by 10.92%, as shares sank -4.27% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -24.83% lower at present.
During the last 5 trading sessions, CMND rose by +19.94%, which changed the moving average for the period of 200-days by -32.53% in comparison to the 20-day moving average, which settled at $1.0189. In addition, Clearmind Medicine Inc saw -18.84% in overturn over a single year, with a tendency to cut further losses.
Stock Fundamentals for CMND
The total capital return value is set at -1.66. Equity return is now at value -125.61, with -59.45 for asset returns.
Based on Clearmind Medicine Inc (CMND), the company’s capital structure generated 0.02 points at debt to capital in total, while cash flow to debt ratio is standing at -101.54. The debt to equity ratio resting at 0.02. The interest coverage ratio of the stock is -106.05.
Currently, EBITDA for the company is -5.85 million with net debt to EBITDA at 1.08. The liquidity ratio also appears to be rather interesting for investors as it stands at 1.72.
Conclusion
To sum up, Clearmind Medicine Inc (CMND) has seen a bad performance recently. Analysts have differing views on the stock, with some seeing it as a “buy” and others as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
